A Phase 1b, exploratory clinical study of TG-02 in pediatric patients with diffuse intrinsic pontine glioma (DIPG)
Latest Information Update: 05 Sep 2019
At a glance
- Drugs Zotiraciclib (Primary)
- Indications Diffuse intrinsic pontine glioma
- Focus Adverse reactions
- Sponsors Adastra Pharmaceuticals
- 04 Sep 2019 Status changed from planning to recruiting, as reported in an Pharmaceuticals media release.
- 07 Jan 2019 New trial record
- 03 Jan 2019 According to a Adastra Pharmaceuticals media release, the company expects to initiate this study in the second quarter of 2019.